Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Self-Reported Prostate Cancer Screening

Summary Indicator Report Data View Options

Year2012201320142015201620172018201920200.0%5.0%10.0%15.0%20.0%25.0%30.0%Estimated Percentage of Men Aged 40 Years and Older (Age-adjusted)Self-Reported Prostate Cancer Screening by Year, New Jersey, 2012 to 2020
Year2012201320142015201620172018201920200.0%10.0%20.0%30.0%40.0%50.0%60.0%Estimated Percentage of Men Aged 40 Years and Older (Age-adjusted)Self-Reported Prostate Cancer Screening by Race/Ethnicity, New Jersey, 2012 to 2020WhiteBlackHispanicAsian

Self-Reported Prostate Cancer Screening by County, New Jersey, 2017-2020

Atlantic
Bergen
Burlington
Camden
Cape May
Cumberland
Essex
Gloucester
Hudson
Hunterdon
Mercer
Middlesex
Monmouth
Morris
Ocean
Passaic
Salem
Somerset
Sussex
Union
Warren

Base Map

Overlays

Labels

Choropleth

×

Estimated Percentage of Men Aged 40 Years and Older (Age-adjusted)

  • Undetermined
  • 10.6% - 14.1%
  • 14.1%+ - 19.1%
  • 19.1%+ - 23.8%
  • 23.8%+ - 27.2%
Grouping: Jenks Natural Breaks - Original
30 km
20 mi
Leaflet | © OpenStreetMap contributors

Why Is This Important?

Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.

Definition

The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.

Data Source

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health
(http://www.nj.gov/health/chs/njbrfs/)

How the Measure is Calculated

Numerator:The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Denominator:The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question.

How Are We Doing?

In 2020, about 15% of New Jersey men aged 40 and over reported that a doctor, nurse, or other health professional have talked to them about the advantages and disadvantages of the PSA test.

Available Services

NJDOH has many programs and partnerships related to cancer resources, cancer information and cancer prevention. http://nj.gov/health/ces/public/resources/